VG Life Sciences Inc. Moves to Restore Financial Accountability & Completes Prior Year Audits, Plans to File Form 10
01 mai 2014 10h22 HE
|
VG Life Sciences
SANTA BARBARA, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune and...
VG Life Sciences, Inc.'s Reports on Clinical Outcomes in Phase I Cancer Study
14 mars 2014 06h06 HE
|
VG Life Sciences
SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability...
VG Life Sciences, Inc. Increases Authorized Shares
03 janv. 2014 00h14 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Jan. 3, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the...
VG Life Sciences, Inc. December 2013 Shareholder Letter
18 déc. 2013 01h11 HE
|
VG Life Sciences
SANTA BARBARA, Calif., Dec. 18, 2013 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., VGLS (formerly known as Viral Genetics) is a Santa Barbara, California-based biotechnology company focused on...